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Introduction: Gastrointestinal stromal tumors (GIST) are uncommon mesenchymal tumors of the gastrointestinal
(GI) tract, accounting for 0.1% to 3% of all GI malignancies. Paediatric GIST have an annual incidence of 0.02 per
million children, have a female predisposition, are usually located in the stomach (50–60%) and in up to 85% of
cases CD117-cKit or PDGFRA mutation is absent, resulting in a decreased efficacy of the target therapy.
Case description: We report the case of an incidentally diagnosed gastric GIST in a 14-year-old boy with multiple
malformations. Genetic tests and Kariotype resulted negative.
Recently, an abdominal US visualized an hypoechoic heterogeneous abdominal mass. The common tumor markers
resulted negative and the abdominal CT-scan confirmed the presence of a solid round lesion (42×36mm) in contact
with the stomach and the pancreas. Laparoscopy allowed the recognition and the removal of the nodular mass at
the posterior margin of the stomach. The histopathologic and the molecular biology findings were consistent with
a kit-wilde type GIST. Surgical margins were microscopically free of tumor cells.
These results justify the decision not to add other surgical or medical therapy. However, for high risk of recurrence
and metastasis, a close follow-up was started.
Discussion and evaluation: GIST are asymptomatic in 10% to 30% of patients or present nonspecific symptoms
and signs. These tumors present usually irregular, lobulated and ulcerated. CT-scan of the abdomen and pelvis or
magnetic resonance imaging (MRI) are mandatory in the diagnostic work-up. The final diagnosis is based on histology
and immunohistochemistry. Surgery is the first-line treatment in patients with localized disease.
Conclusion: Guidelines for the management of pediatric GIST are not presently available for the paucity of reports
and data. However it is widely accepted that surgery is the first-line treatment and gross resection with negative
microscopic margins can be considered therapeutic and lead to full remission of the pathology. Laparoscopy is a
safe surgical approach for the exploration of the abdominal cavity, the evaluation of the disease and the complete
removal of the tumor.
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Gastrointestinal stromal tumors (GISTs) are uncommon
mesenchymal tumors of the gastrointestinal (GI) tract
accounting for 0.1% to 3% of all GI malignancies
(Gunaydin et al. 2012). In children the true incidence is
not available for the rarity of the pathology and the dif-
ficulty of the correct diagnosis (Benesch et al. 2009).
The most accurate epidemiological data on paediatric
GIST (less than 14 years) show an annual incidence of* Correspondence: tommaso.gargano2@unibo.it
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in any medium, provided the original work is p0.02 per million children (Benesch et al. 2009; Guhyun K
et al. 2013), 1.4% of all cases (Park et al. 2006; Jagannathan
et al. 2012).
In children, GIST can occur sporadically or concurrently
with genetic syndromes, including familial GIST with
germline KIT mutation, neurofibromatosis type 1, Carney
triad and Carney–Stratakis syndrome (Benesch et al. 2009;
Guhyun K et al. 2013; Park et al. 2006; Vaughan et al.
2011).
Generally paediatric GIST has a female predisposition
(Gunaydin et al. 2012; Guhyun K et al. 2013; Park et al.
2006; Hayashi et al. 2005; Tran et al. 2013) and occursOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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Park et al. 2006; Hayashi et al. 2005; Tran et al. 2013) or in
the small intestines (Gunaydin et al. 2012; Durham et al.
2004; Hayashi et al. 2005; Tran et al. 2013). In up to 85%
of paediatric cases c-kit/CD-117 or PDGFRA (Platelet-
Derived Growth Factor Receptor Alpha) mutation is
absent and it may result in decreased efficacy in target-
based therapy with tyrosine kinase receptor inhibitors
(Benesch et al. 2009; Tran et al. 2013).
Guidelines for the management of paediatric GIST are
not clear and often derives from the adult literature
(Benesch et al. 2009; Hayashi et al. 2005), however it is
widely accepted that surgery is the first-line treatment
(Gunaydin et al. 2012; Benesch et al. 2009; Hayashi et al.
2005) and gross resection with negative microscopic mar-
gins may lead to full remission of the pathology (Gunaydin
et al. 2012; Benesch et al. 2009; Durham et al. 2004;
Hayashi et al. 2005; Tran et al. 2013). Despite a high rate
of metastases, tumor recurrence and limited response to
tyrosine kinase inhibitors, paediatric GIST have a relatively
benign clinical course (Gunaydin et al. 2012; Benesch et al.
2009; Jagannathan et al. 2012; Tran et al. 2013).
Case report
We report the case of a 14 year-old boy with an inciden-
tal US diagnosis of abdominal solid mass. The patient
was born at full-term, with pre-natal diagnosis of a car-
diovascular malformation: ventricular septal defect, coarc-
tation of the aorta and bicuspid aortic valve. He wasFigure 1 Abdominal CT-scan with contrast: solid round lesion (42×36operated at birth and one month later to correct the
malformations and the consequently subaortic stenosis.
The post-operative course was complicated by sepsis and
high pressure hydrocephalus, corrected by a ventriculoper-
itoneal shunt. The young boy was affected by congenital
bilateral sensorineural deafness and at 6 years, a cochlear
device was implanted. He suffered of musculo-skeletal
malformation at shoulder girdle and growth retardation
and of IgM deficiency and IgG progressive decrease.
Genetic tests were conducted to evaluate the presence
of a syndromic pattern: Kariotype, Connexin 26 mutation
(responsible for severe hearing loss), subtelomeric rearrange-
ments, 22q delation, CGH array; that resulted negative.
In the last period the patient was in good general con-
dition, with no symptoms referred. During the auxologic
control, the abdominal US visualized an hypoechoic het-
erogeneous mass (4 cm) in the perihepatic region corris-
ponding to the 3rd hepatic segment, antero-laterally to
the gastric antrum. Lab test revealed a mild neutrophilic
leukocytosis and anemia. The common tumor markers:
AFP, beta-hCG, CEA, ferritin, LDH, urine HVA/VMA
resulted negative.
An abdominal computed tomography (CT-scan) with
contrast was executed to characterize the lesion. It shown
a large solid round lesion (42×36mm) in the context of
the mesenteric adipose tissue, under the left liver lobe, in
contact medially with the lesser curvature of the stomach
and behind with the pancreas (Figure 1). The lesion shown
a faint and inhomogeneous enhancement in the arterialcm) adjacent to the left liver lobe, the stomach and the pancreas.
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malities to lymph nodes and the abdominal organs were
not visualized. The neck and thoracic CT-scan did not
reveal the presence of other lesions or masses, except for
the known skeletal dysmorphia. The upper gastrointestinal
contrast study did not visualized any external compression
of the stomach.
Laparoscopic surgical approach was conducted to evalu-
ate the extension of the lesion and to make diagnosis of
the origin of the mass. A subombelical incision and the
opening of the peritoneum was realized to insert the
5 mm trocar. The CO2 was insuffled with a flow of
1 L/min and an intra-abdominal pressure of 10 mmHg.
The 0° optic was inserted and two other trocars, 5 and
a 10 mm, were positioned in the right and the left flank
respectively. The exploration of the abdominal cavity was
difficult for the presence of several omental adhesions,
partially removed with a dissector and the LigaSure. The
ventriculoperitoneal shunt was visualized in the right
hypochondrium. At the posterior margin of the body of
the stomach a 4 cm solid and nodular formation was vi-
sualized and handled with endoscopic blunt tip dissectors.
A 10 mm Stappler was positioned in a macroscopically
tumor-free area of the stomach and the lesion was cut.
The specimen was finally inserted in an Endobag and
removed through the umbilical wound (Figure 2a,b). A
sample of omentum was removed with another endo-
bag for the histopathologic examination. After the
control of the hemostasis, the trocars were removed
and the abdominal wall sutured. The patient tolerate
the procedure well and his postoperative course was
unremarkable.
Histopathologic examination of the mass revealed the
presence of epithelioid and spindle cells with low mitotic
activity (less than 5 × 50 high-power field (HPF)), erosions
of the mucosa and serous and no evidence of necrosis
(Figure 3a,b,c). Surgical margins of the mass and the
omentum were microscopically free of tumor cells. Tumor
cells stained positive for CD117 (Figure 4a) and DOG-1
(Figure 4b), negative for S-100, desmine, vimentine,Figure 2 Intraoperative finding. a: the solid nodular mass was cut with 1smooth muscle actin, and neuron-specific enolase by immu-
nohistochemistry. Genetic analysis were performed search-
ing CKIT mutations (exons 9, 11, 13, 14, 17) and PDGFRA
mutations (exons 12,14,18). In both genes, mutation
were absent. So the tumor was characterized as a kit-
wilde type GIST.
These results justify the decision not to add other
surgical or medical therapy. However, for high risk of
recurrence and metastasis, a close follow-up will be
conducted.
Discussion and evaluation
Gastrointestinal stromal tumors (GIST) are the most com-
mon mesenchymal tumors of the gastrointestinal tract
(Gunaydin et al. 2012; Benesch et al. 2009; Durham et al.
2004; Guhyun K et al. 2013; Park et al. 2006; Jagannathan
et al. 2012; Hayashi et al. 2005) accounting for 6.5 to 14.5
per million per year (Benesch et al. 2009). Men older than
40 years are predominantly affected (95% of all) (Gunaydin
et al. 2012; Park et al. 2006; Jagannathan et al. 2012),
with a peak incidence in the sixth and seventh decades
(Gunaydin et al. 2012; Guhyun K et al. 2013; Park et al.
2006; Hayashi et al. 2005; Tran et al. 2013). Among chil-
dren and adolescents GIST are very uncommon (Benesch
et al. 2009; Hayashi et al. 2005) and have two peaks of in-
cidence: less than 1-year-old and between 10 and 15 years
old (Hayashi et al. 2005). The true incidence of pediatric
GIST is not available for the rarity of the pathology
and the lack of a prospective standardized registration
(Benesch et al. 2009). Furthermore, the immunohisto-
chemistry has recently allowed the accurate differenti-
ation of GIST from other mesenchimal tumors such as
leiomyomas, leiomyosarcomas, and plexosarcomas (Durham
et al. 2004). The most accurate epidemiological data on
paediatric GIST come from the UK National Registry of
Childhood Tumours showing an annual incidence of
0.02 per million children below the age of 14 years
(Benesch et al. 2009; Guhyun K et al. 2013) represent-
ing 1.4% of all GIST cases (Park et al. 2006; Jagannathan
et al. 2012; Tran et al. 2013).0mm Stappler. b: surgical specimen measuring 4 cm in diameter.
Figure 3 Histopathologic examination of the mass: spindle and epithelioid cells, low mitotic rate (less than 5 × 50 HPF), no
evidence of necrosis, erosions of the mucosa and serous. a: GIST’s cells and gastric wall’s cells 10 ×. b: GIST’s cells 20×. c: GIST’s cells
and gastric wall’s cells.
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etic syndromes, including familial GIST with germline
KIT mutation, neurofibromatosis type 1, Carney triad and
Carney–Stratakis syndrome (Benesch et al. 2009; Guhyun
K et al. 2013; Park et al. 2006; Vaughan et al. 2011). Carney
triad, firstly described in 1977 by J. Aidan Carney, associ-
ates gastric leiomyosarcoma, extra-adrenal paraganglioma
and pulmonary chondroma (Benesch et al. 2009; Park et al.
2006; Vaughan et al. 2011). Carney–Stratakis syndrome or
Carney–Stratakis is an inherited tumor syndrome com-
prising GIST and paragangliomas (Benesch et al. 2009;
Vaughan et al. 2011).
GIST derived from the interstitial cells of Cajal (ICC)
(Tran et al. 2013) that are distributed along the gastro-
intestinal tract and are considered the pacemaker for mus-
cular motility of the gastrointestinal tract (Durham et al.
2004). Approximately 60% of GIST in adults presents the
mutations of c-kit in the juxtamembranous domain. The
alteration of this proto-oncogene leads to a “gain of func-
tion” promoting growth or preventing apoptosis (Durham
et al. 2004). In up to 85% of paediatric cases, KIT or
PDGFRA (Platelet-derived Growth Factor Receptor Alpha)
mutation is absent (non-mutation kit genotype, termed
kit-wilde type (WT GIST). However, the expression of
phosphorylated KIT or the biochemical activation of KIT
downstream molecules (AKT, mTOR, PDK1, MAPK) in
the WT-GIST, results, similarly, in the uncontrollable
proliferation of ICC. The lack of KIT gene mutation mayFigure 4 Immunohistochemical examination. a: tumor cells stained posresult in decreased efficacy in target-based therapy with
tyrosine kinase receptor inhibitors (Benesch et al. 2009;
Tran et al. 2013).
These tumors can arise anywhere in the GI tract, but
the vast majority, both in adults and in children, occurs
in the stomach (50–60%) (Benesch et al. 2009; Guhyun K
et al. 2013; Park et al. 2006; Hayashi et al. 2005; Tran et al.
2013) and in the small intestines (20–30%) (Gunaydin
et al. 2012; Durham et al. 2004; Hayashi et al. 2005; Tran
et al. 2013). Occurrence of multiple tumors is observed
both in syndromic and sporadic form and regional recur-
rence rates are high in pediatric gastric GIST (Park et al.
2006). The liver (19%), the peritoneum (16%) and lymph
nodes (11%) are the most common sites of metastasis;
more rarely the lungs, pleura, bones, subcutaneous tissues
(Jagannathan et al. 2012) and brain (one case reported)
(Benesch et al. 2009; Jagannathan et al. 2012).
GIST are asymptomatic in 10% to 30% of patients
(Gunaydin et al. 2012; Benesch et al. 2009) or present non-
specific symptoms and signs (Benesch et al. 2009; Tran
et al. 2013). In many cases they are discovered incidentally
during imaging, endoscopy or laparotomy for unrelated
problems (Gunaydin et al. 2012). The most common
clinical features are anaemia (39%), abdominal pain (16%),
palpable abdominal mass (10%), gastrointestinal acute or
chronic bleeding with hematemesis or melena, anaemia
related symptoms, fatigue, dizziness, exertional dyspnea,
or syncope (Gunaydin et al. 2012; Durham et al. 2004;itive for CD117-c-KIT. b: positive for DOG-1.
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cause partial intestinal or biliary obstruction, dysphagia,
hemoperitoneum, intussusception (Gunaydin et al. 2012;
Park et al. 2006; Tran et al. 2013).
The differential diagnoses for large left upper quadrant
mass include embryonal sarcoma, cystic mesenchymal
hamartoma, primary pancreatic tumor, splenic pseudocyst,
adrenal cortical carcinoma and primitive neuroectodermal
tumor (PNET)/Askin tumor arising from the left hemi-
diaphram (Park et al. 2006).
These tumors present usually irregular, lobulated and
ulcerated (Durham et al. 2004). They involve the muscu-
laris propria with extramural, mural, and intramural ex-
tension (Tran et al. 2013; Park et al. 2006; Durham et al.
2004) or can be exophytic with a small pedicle (Park
et al. 2006).
CT-scan of the abdomen and pelvis or magnetic res-
onance imaging (MRI) are mandatory in the diagnostic
work-up and in monitoring the disease, as well as in the
detachment of hepatic metastases (Benesch et al. 2009;
Durham et al. 2004; Tran et al. 2013). CT-scan shows sin-
gle or multiple solid-nodular masses which does not
enhance with intravenous contrast (Durham et al. 2004;
Park et al. 2006; Tran et al. 2013). MRI shows a rounded
variable T1 and T2 signal with areas of necrosis and
hemorrhage, that does not significantly enhance with
intravenous gadolinium (Durham et al. 2004; Park et al.
2006; Tran et al. 2013). The lesions correspond to well
circumscribed, often round filling defects on gastro-
intestinal contrast series that were absent in the case pre-
sented. In this case we have been obliged to choose the
CT scan because of the presence of a cochlear implant
that contraindicated MRI. Since GIST has the propensity
for submucosal growth, additional endosonography can
be utilized (Benesch et al. 2009). Fluorodeoxyglucose-
positron emission tomography (FDG-PET) is useful for
the diagnosis, the monitoring of the disease progression
and treatment response (Gunaydin et al. 2012; Benesch
et al. 2009; Tran et al. 2013) and the evaluation of me-
tastases (Durham et al. 2004; Tran et al. 2013).
The final diagnosis is based on histology and immuno-
histochemistry. Tissue samples can be obtained either by
(endoscopic or percutaneous) biopsy or resection of
the tumor. Whereas endoscopic biopsies are often non-
diagnostic and percutaneous biopsies may increase the
risk of hemorrage and intra-peritoneal tumor spillage,
surgical tumor resection is preferred (Gunaydin et al.
2012; Bhatnagar 2010). The mass, on preoperative im-
aging, has the characteristic of a sarcoma. Therefore,
considering the presence of a single lesion, the surgical
approach was decided to get a clear diagnosis, without
further investigations. Intraoperatively, the mass was re-
movable, so we performed a complete resection. The histo-
pathologic examination of a GIST usually reveales spindlecells with atypical nuclei, organized in perpendicular
bunches (Gunaydin et al. 2012; Durham et al. 2004).
On immunohistochemistry assay the tumor cells stained
uniformly for stem cell factor CD34 and c-kit (CD-117),
variably positive for SMA and S-100, and negative for des-
min (Gunaydin et al. 2012; Durham et al. 2004). Molecular
biological examination detects KIT or PDGFRA mutations
in 78% of GIST in young adults and PDGFRA mutants
seem to be more frequent in younger patients (17% vs
4%). Recently, germline mutations encoding the succinate
dehydrogenase (SDH) subunits (SDH B, SDH C, and SDH
D) have been identified in Carney triad-associated and
pediatric GIST (Guhyun K et al. 2013; Jagannathan et al.
2012). Thus it has been proposed that GISTcan be divided
into two distinctive subgroups on the basis of SDHB IHC.
Type 1 (SDHB positive) tumors are common in adults,
can occur anywhere in the gastrointestinal tract, have
an equal gender distribution, and usually have KIT or
PDGFRA mutations. Type 2 (SDHB negative), are typical
in childhood and young adulthood and occur almost ex-
clusively in the stomach (Guhyun K et al. 2013). Another
mutation that can be founded in these tumors is BRAF
mutation (in 1% of cases). There are no data about the sig-
nificance of these mutation in term of prognosis.
Surgery is the first-line treatment (Gunaydin et al. 2012;
Benesch et al. 2009; Hayashi et al. 2005) but there are no
consensus guidelines and no prospective therapeutic treat-
ment studies (Hayashi et al. 2005): current guideless for
management and treatment of pediatric GISTs are based
on clinical experience and data from case reports and case
series (Tran et al. 2013).
For non metastatic resectable tumors, complete surgical
resection is the gold standard.
Gross surgical resection with negative microscopic mar-
gins may lead to full remission (Gunaydin et al. 2012;
Benesch et al. 2009; Durham et al. 2004; Hayashi et al.
2005; Tran et al. 2013) and endoscopic approach could be
preferred in the treatment of small-sized GIST (Gunaydin
et al. 2012). Resection of localized GIST of the stomach is
allowed by antrectomy, partial (distal) gastrectomy or by
wedge resection, subtotal or total gastrectomy (Benesch
et al. 2009). We decided for a laparoscopic wedge resec-
tion and an omentectomy to exclude its involvement.
Currently, laparoscopy is gaining an increasingly im-
portant role in oncology, especially for small lesions and
in cases in which oncologic criteria can be respected with
this technique. Stating that preoperative imaging didn’t
revealed lymph-node involvement, we didn’t performed
lymphadenectomy waiting for a correct diagnosis from
histology. Futhermore, intraoperatively we noted several
adhesions due to previous surgery that made difficult to
reach lymphatic stations.
In several case series, 20-29% of pediatric patients have
metastases at diagnosis, usually localized in the liver,
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Since lymph node involvement is greater in pediatric pa-
tient, an active search for occult lymph node involvement
sould be performed when a GIST is suspected and the pro-
cedure is technically possible. Nevertheless, in case of
diffuse disease, extensive lymphadenectomy has not been
shown to improve survival (Durham et al. 2004; Hayashi
et al. 2005).
During surgical procedure it is important to avoid tumor
rupture/spill as this is associated to high risk of recur-
rence. In Fact some Authors reported a recurrence rate of
78% in patients with intraoperative or preoperative tumor
rupture (Janeway and Weldon 2012).
The use of conventional cytotoxic chemotherapy is not
recommended for the treatment of pediatric GIST because
they give poor responses (Benesch et al. 2009; Durham
et al. 2004; Hayashi et al. 2005; Bhatnagar 2010). Cur-
rently, an oral protein tyrosine kinase inhibitor, imatinib
mesylate, has shown promising antiproliferative and proa-
poptotic effects against the mutated, constitutively active
transmembrane CD-117 receptor found in most GIST
(Durham et al. 2004). After the approval by Food and
Drug Administration (USA) in 2002, this drug found
increasing application for adult GIST in adjuvant ther-
apy, improving the overall tumor-free survival and redu-
cing of recurrences (Bhatnagar 2010). Thus, all tumors
should be evaluated for KIT and PDGFRA mutations to
determine efficacy of targeted therapy with imatinib or
sunitinib (Benesch et al. 2009). Sunitimib is a tyrosine-
kinase inhibitor 10 times more potent than imatinib
that seems to be effective in adult patients with imatinib-
resistant GIST, but there are no sufficient data to establish
the real efficacy in pediatric patients (Janeway KA &
Pappo 2012).
WT GIST had poor or absent response to TKI and the
adjuvant therapy with these drugs seems not to increase
the recurrence free survival. Moreover, emerging data
suggest that long-term exposure to imatinib could have
toxic effect on pediatric patient, so the use of TKI isn’t
presently recommended.
Paediatric GIST have a relatively benign clinical course
despite a high rate of metastases, tumor recurrence and
limited response to tyrosine kinase inhibitors (Gunaydin
et al. 2012; Benesch et al. 2009; Jagannathan et al. 2012;
Tran et al. 2013). Recurrence after complete remission
involves 25% of patients in most series, but less than
10% of patients with metastatic disease die because of
GIST. The 5-year survival rates for GIST ranges from
32% to 63% after complete surgical resection (Durham
et al. 2004).
Few risk stratification schemes have been demonstrated
to predict risk of recurrence in adults. Principal criteria
are tumor size, tumor site, mitotic index, tumor rupture.
According to these criteria, primary tumor size greaterthan 5 cm (Gunaydin et al. 2012; Durham et al. 2004), mi-
totic index greater than 5 mitoses per 50 HPFs, spindle
cell morphology, shorter disease-free interval, and non-
resected metastatic disease are associated with a worse
prognosis (Gunaydin et al. 2012). Unfortunately, the risk
stratification criteria are probably not relevant to children
with WT GIST.
Metastatic, unresectable WT GIST has a more indo-
lent course and the mean survival from the development
of metastases is 15 years. Considering the limits of med-
ical therapy, cure is unlikely, so the goal should be the
disease control and symptom management. Surgery should
be considered because of the long time these patients can
live with GIST, but aggressive procedure leaving macro-
scopic disease should be avoided and a proper counselling
is mandatory considering that a complication rate of 60% is
reported. In metastatic, unresectable WT GIST, a combined
approach with TKI and surgery can be considered. Imatinib
has some activity in adult with WT GIST but responses in
children appear to be uncommon. Sunitinib appears to be
more effective in pediatric and adult GIST but the effect is
rare and is typically a disease stabilization. Other TKI are
nilotinib and masitinib but their activity in WT GIST has
not been assessed. Recently, insulin-like growth factor 1 re-
ceptor has been founded to be overexpressed in WT GIST
and could be a new target for therapy.
Because of the high recurrence rate, a strict surveillance
is recommended. According to most of Authors, axial im-
aging with CT scan every 3–6 month for the first 5 years
after surgery represent a useful tool for the follow up. MRI
could be used instead of CT to avoid excessive radiation
exposure. In this case, MRI was contraindicated because
of the presence of cochlear implant, so we decided to use
abdominal ultrasounds and chest X-Ray alternatively to
CT scans every 4–6 months. Currently, the disease is in
remission at 11 months after surgery.Conclusions
It is widely accepted that surgery is the first-line treat-
ment in children and adolescents with resectable GIST
(Gunaydin et al. 2012; Benesch et al. 2009; Hayashi et al.
2005) and gross resection with negative microscopic
margins may lead to full remission (Gunaydin et al. 2012;
Benesch et al. 2009; Durham et al. 2004; Hayashi et al.
2005; Tran et al. 2013). Laparoscopy could be considered
a safe and effective surgical approach for the exploration
of the abdominal cavity to evaluate the extension of the
disease and for the complete removal of the tumor.Consent
Written informed consent was obtained from the patient's
parent for the publication of this report and any accom-
panying images.
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